Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2016 Jan;34(1):7-16.
doi: 10.1016/j.det.2015.08.002.

Prevalence, Risk Factors, and Comorbidities of Hidradenitis Suppurativa

Iben Marie Miller  1 , Rachel J McAndrew  2 , Iltefat Hamzavi  3
Affiliations
Review

Prevalence, Risk Factors, and Comorbidities of Hidradenitis Suppurativa

Iben Marie Miller et al. Dermatol Clin. 2016 Jan.

Abstract

It is challenging to estimate a true prevalence of hidradenitis suppurativa (HS) because it is underdiagnosed and misdiagnosed. Prevalences have been reported from 0.00033% to 4.1%. The incidence seems to be rising. In addition to dermatologic symptoms, HS is associated with metabolic syndrome, and increased cardiovascular risk. The majority of HS patients are smokers. Additional somatic comorbidities complicating HS include autoimmune conditions, follicular syndromes, rheumatologic conditions, and malignancies. HS patients are troubled by psychological comorbidities. When treating HS patients it is imperative not only to treat the skin symptoms, but also address the screening and treatment of possible comorbidities.

Keywords: Hidradenitis suppurativa; Incidence; Malignancies; Metabolic syndrome; Prevalence; Psychological comorbidities; Smoking; Spondylarthritis.

PubMed Disclaimer